| 000 | 01157 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516183755.0 | ||
| 264 | 0 | _c20140212 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1572-0241 | ||
| 024 | 7 |
_a10.1038/ajg.2013.141 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGovani, Shail M | |
| 245 | 0 | 0 |
_aAnti-adhesion therapies and the rule of 3 for rare events. _h[electronic resource] |
| 260 |
_bThe American journal of gastroenterology _cDec 2013 |
||
| 300 |
_a1831-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aCell Migration Inhibition _xdrug effects |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukoencephalopathy, Progressive Multifocal _xchemically induced |
| 650 | 0 | 4 | _aNatalizumab |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aWaljee, Akbar K | |
| 700 | 1 | _aHiggins, Peter D R | |
| 773 | 0 |
_tThe American journal of gastroenterology _gvol. 108 _gno. 12 _gp. 1831-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ajg.2013.141 _zAvailable from publisher's website |
| 999 |
_c23331794 _d23331794 |
||